166 related articles for article (PubMed ID: 18086662)
41. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E
Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
[TBL] [Abstract][Full Text] [Related]
43. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene.
Agazie Y; Ischenko I; Hayman M
Oncogene; 2002 Jan; 21(5):697-707. PubMed ID: 11850798
[TBL] [Abstract][Full Text] [Related]
44. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
45. Fcgamma receptor signaling in primary human microglia: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction.
Song X; Tanaka S; Cox D; Lee SC
J Leukoc Biol; 2004 Jun; 75(6):1147-55. PubMed ID: 14982949
[TBL] [Abstract][Full Text] [Related]
46. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
47. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways.
Rice PL; Peters SL; Beard KS; Ahnen DJ
Mol Cancer Ther; 2006 Mar; 5(3):746-54. PubMed ID: 16546990
[TBL] [Abstract][Full Text] [Related]
48. Sodium Selenite Enhanced the Anti-proliferative Effect of MEK-ERK Inhibitor in Thyroid Cancer Cells.
Kim JB; Yang EY; Woo J; Kwon H; Lim W; Moon BI
In Vivo; 2020; 34(1):185-190. PubMed ID: 31882478
[TBL] [Abstract][Full Text] [Related]
49. RSK activation via ERK modulates human colon cancer cells response to PTHrP.
Calvo N; Carriere P; Martin MJ; Gentili C
J Mol Endocrinol; 2017 Jul; 59(1):13-27. PubMed ID: 28385776
[TBL] [Abstract][Full Text] [Related]
50. Src and focal adhesion kinase mediate mechanical strain-induced proliferation and ERK1/2 phosphorylation in human H441 pulmonary epithelial cells.
Chaturvedi LS; Marsh HM; Basson MD
Am J Physiol Cell Physiol; 2007 May; 292(5):C1701-13. PubMed ID: 17215324
[TBL] [Abstract][Full Text] [Related]
51. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M
Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914
[TBL] [Abstract][Full Text] [Related]
52. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells.
Watters JJ; Chun TY; Kim YN; Bertics PJ; Gorski J
Mol Endocrinol; 2000 Nov; 14(11):1872-81. PubMed ID: 11075818
[TBL] [Abstract][Full Text] [Related]
53. The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils.
Dewas C; Fay M; Gougerot-Pocidalo MA; El-Benna J
J Immunol; 2000 Nov; 165(9):5238-44. PubMed ID: 11046057
[TBL] [Abstract][Full Text] [Related]
54. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
[TBL] [Abstract][Full Text] [Related]
55. Suppression of IL-8-Src signalling axis by 17β-estradiol inhibits human mesenchymal stem cells-mediated gastric cancer invasion.
Liu CJ; Kuo FC; Wang CL; Kuo CH; Wang SS; Chen CY; Huang YB; Cheng KH; Yokoyama KK; Chen CL; Lu CY; Wu DC
J Cell Mol Med; 2016 May; 20(5):962-72. PubMed ID: 26945908
[TBL] [Abstract][Full Text] [Related]
56. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
57. v-src-induced cell shape changes in rat fibroblasts require new gene transcription and precede loss of focal adhesions.
Meijne AM; Ruuls-Van Stalle L; Feltkamp CA; McCarthy JB; Roos E
Exp Cell Res; 1997 Aug; 234(2):477-85. PubMed ID: 9260918
[TBL] [Abstract][Full Text] [Related]
58. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
Silvany RE; Eliazer S; Wolff NC; Ilaria RL
Oncogene; 2000 Sep; 19(39):4523-30. PubMed ID: 11002425
[TBL] [Abstract][Full Text] [Related]
59. Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells.
Serova M; Ghoul A; Benhadji KA; Faivre S; Le Tourneau C; Cvitkovic E; Lokiec F; Lord J; Ogbourne SM; Calvo F; Raymond E
Mol Cancer Ther; 2008 Apr; 7(4):915-22. PubMed ID: 18413805
[TBL] [Abstract][Full Text] [Related]
60. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts.
Matsuyoshi N; Hamaguchi M; Taniguchi S; Nagafuchi A; Tsukita S; Takeichi M
J Cell Biol; 1992 Aug; 118(3):703-14. PubMed ID: 1639852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
